Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients

重症 COVID-19 患者的细胞类型特异性免疫失调

阅读:14
作者:Changfu Yao, Stephanie A Bora, Tanyalak Parimon, Tanzira Zaman, Oren A Friedman, Joseph A Palatinus, Nirmala S Surapaneni, Yuri P Matusov, Giuliana Cerro Chiang, Alexander G Kassar, Nayan Patel, Chelsi E R Green, Adam W Aziz, Harshpreet Suri, Jo Suda, Andres A Lopez, Gislâine A Martins, Barry R Stri

Abstract

Recent studies have demonstrated immunologic dysfunction in severely ill coronavirus disease 2019 (COVID-19) patients. We use single-cell RNA sequencing (scRNA-seq) to analyze the transcriptome of peripheral blood mononuclear cells (PBMCs) from healthy (n = 3) and COVID-19 patients with moderate disease (n = 5), acute respiratory distress syndrome (ARDS, n = 6), or recovering from ARDS (n = 6). Our data reveal transcriptomic profiles indicative of defective antigen presentation and interferon (IFN) responsiveness in monocytes from ARDS patients, which contrasts with higher responsiveness to IFN signaling in lymphocytes. Furthermore, genes involved in cytotoxic activity are suppressed in both natural killer (NK) and CD8 T lymphocytes, and B cell activation is deficient, which is consistent with delayed viral clearance in severely ill COVID-19 patients. Our study demonstrates that COVID-19 patients with ARDS have a state of immune imbalance in which dysregulation of both innate and adaptive immune responses may be contributing to a more severe disease course.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。